(19)
(11) EP 3 886 871 A1

(12)

(43) Date of publication:
06.10.2021 Bulletin 2021/40

(21) Application number: 19888596.4

(22) Date of filing: 27.11.2019
(51) International Patent Classification (IPC): 
A61K 35/16(2015.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/16
(86) International application number:
PCT/US2019/063659
(87) International publication number:
WO 2020/113041 (04.06.2020 Gazette 2020/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.11.2018 US 201862773388 P
19.12.2018 US 201816225210
10.05.2019 US 201916409543

(71) Applicant: HDL Therapeutics, Inc.
Vero Beach, FL 32960 (US)

(72) Inventors:
  • BREWER, Hollis, Bryan, Jr.
    Potomac, MD 20854 (US)
  • MATIN, Michael, M.
    Short Hills, NJ 07078 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) METHODS FOR TREATING LIPID-RELATED DISEASES INCLUDING XANTHOMAS, CAROTID ARTERY STENOSES, AND CEREBRAL ATHEROSCLEROSIS